CN103520621A - Traditional Chinese medicine composition for treating senile cataract and preparation method thereof - Google Patents
Traditional Chinese medicine composition for treating senile cataract and preparation method thereof Download PDFInfo
- Publication number
- CN103520621A CN103520621A CN201310509764.9A CN201310509764A CN103520621A CN 103520621 A CN103520621 A CN 103520621A CN 201310509764 A CN201310509764 A CN 201310509764A CN 103520621 A CN103520621 A CN 103520621A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicine
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 123
- 208000002177 Cataract Diseases 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 201000008525 senile cataract Diseases 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 210000003608 fece Anatomy 0.000 claims abstract description 18
- 210000003038 endothelium Anatomy 0.000 claims abstract description 13
- 238000011282 treatment Methods 0.000 claims description 68
- 210000000582 semen Anatomy 0.000 claims description 60
- 241000628997 Flos Species 0.000 claims description 55
- 229940079593 drug Drugs 0.000 claims description 45
- 239000000843 powder Substances 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 235000015170 shellfish Nutrition 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 239000003889 eye drop Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 241000195474 Sargassum Species 0.000 claims description 12
- 239000010271 massa medicata fermentata Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- 241001092371 Bergenia Species 0.000 claims description 6
- 235000005903 Dioscorea Nutrition 0.000 claims description 6
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 6
- 239000013078 crystal Substances 0.000 claims description 6
- 235000004879 dioscorea Nutrition 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000001256 steam distillation Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims 3
- 239000008280 blood Substances 0.000 abstract description 71
- 210000004369 blood Anatomy 0.000 abstract description 66
- 210000004185 liver Anatomy 0.000 abstract description 42
- 230000000694 effects Effects 0.000 abstract description 30
- 210000000952 spleen Anatomy 0.000 abstract description 25
- 230000001737 promoting effect Effects 0.000 abstract description 19
- 230000017531 blood circulation Effects 0.000 abstract description 15
- 238000005728 strengthening Methods 0.000 abstract description 10
- 231100000331 toxic Toxicity 0.000 abstract description 10
- 230000002588 toxic effect Effects 0.000 abstract description 10
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 241001521901 Tribulus lanuginosus Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000202903 Bergenia purpurascens Species 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000062995 Cassia occidentalis Species 0.000 abstract 1
- 235000001948 Cassia occidentalis Nutrition 0.000 abstract 1
- 240000008365 Celosia argentea Species 0.000 abstract 1
- 235000000722 Celosia argentea Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 244000112814 pipewort Species 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 36
- 230000036407 pain Effects 0.000 description 35
- 230000004438 eyesight Effects 0.000 description 33
- 208000024891 symptom Diseases 0.000 description 33
- 230000007812 deficiency Effects 0.000 description 32
- 210000003734 kidney Anatomy 0.000 description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
- 210000001015 abdomen Anatomy 0.000 description 22
- 201000010099 disease Diseases 0.000 description 22
- 210000001508 eye Anatomy 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 18
- 241000475481 Nebula Species 0.000 description 17
- 238000012360 testing method Methods 0.000 description 15
- 206010010774 Constipation Diseases 0.000 description 14
- 206010019233 Headaches Diseases 0.000 description 14
- 235000013305 food Nutrition 0.000 description 14
- 231100000869 headache Toxicity 0.000 description 14
- 208000002173 dizziness Diseases 0.000 description 13
- 238000011084 recovery Methods 0.000 description 13
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 12
- 210000000695 crystalline len Anatomy 0.000 description 12
- 208000001848 dysentery Diseases 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000002398 materia medica Substances 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 231100000957 no side effect Toxicity 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 241000411851 herbal medicine Species 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 208000019255 Menstrual disease Diseases 0.000 description 8
- 206010034960 Photophobia Diseases 0.000 description 8
- 208000031971 Yin Deficiency Diseases 0.000 description 8
- 206010003549 asthenia Diseases 0.000 description 8
- 230000029087 digestion Effects 0.000 description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 206010010726 Conjunctival oedema Diseases 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 208000001140 Night Blindness Diseases 0.000 description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 208000009205 Tinnitus Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 201000007227 lymph node tuberculosis Diseases 0.000 description 7
- 238000010791 quenching Methods 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 231100000886 tinnitus Toxicity 0.000 description 7
- 210000001835 viscera Anatomy 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 240000000377 Tussilago farfara Species 0.000 description 6
- 235000004869 Tussilago farfara Nutrition 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000002440 hepatic effect Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 201000004569 Blindness Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000015817 Infant Nutrition disease Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000037920 primary disease Diseases 0.000 description 5
- 230000009978 visual deterioration Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000001142 anti-diarrhea Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 206010008631 Cholera Diseases 0.000 description 3
- 244000281702 Dioscorea villosa Species 0.000 description 3
- 208000003164 Diplopia Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010016807 Fluid retention Diseases 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010029240 Neuritis Diseases 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 241000393340 Triaenophora rupestris Species 0.000 description 3
- 206010047531 Visual acuity reduced Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000001747 pupil Anatomy 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241001620588 Erosaria Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010046543 Urinary incontinence Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 150000002630 limonoids Chemical class 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 240000007185 Albizia julibrissin Species 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000984599 Cypraeidae Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241001624542 Erronea errones Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024214 Lenticular opacities Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 241001625793 Lyncina Species 0.000 description 1
- 241001625933 Lyncina lynx Species 0.000 description 1
- 241000721701 Lynx Species 0.000 description 1
- 241001625898 Mauritia arabica Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001610353 Monetaria Species 0.000 description 1
- 241001610350 Monetaria moneta Species 0.000 description 1
- 241001534756 Mungos Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000689272 Senna sophera Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000608575 Vespertilio Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000009187 flying Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 201000008659 immature cataract Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000001542 lens epithelial cell Anatomy 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 201000004673 mature cataract Diseases 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000009822 qibaomeiran Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310509764.9A CN103520621B (en) | 2013-10-25 | 2013-10-25 | A kind of Chinese medicine composition for the treatment of senile cataract and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310509764.9A CN103520621B (en) | 2013-10-25 | 2013-10-25 | A kind of Chinese medicine composition for the treatment of senile cataract and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103520621A true CN103520621A (en) | 2014-01-22 |
CN103520621B CN103520621B (en) | 2015-10-14 |
Family
ID=49923208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310509764.9A Expired - Fee Related CN103520621B (en) | 2013-10-25 | 2013-10-25 | A kind of Chinese medicine composition for the treatment of senile cataract and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103520621B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860942A (en) * | 2014-03-31 | 2014-06-18 | 刘洁 | Drug for treating phlegm turbidity nasopharynx cancer and preparation method thereof |
CN104288645A (en) * | 2014-10-27 | 2015-01-21 | 邓维新 | Traditional Chinese medicine for treating senile cataract |
CN104623318A (en) * | 2015-03-12 | 2015-05-20 | 周晓明 | Traditional Chinese medicine preparation for pterygium and preparation method of traditional Chinese medicine preparation |
CN104707006A (en) * | 2015-03-03 | 2015-06-17 | 李军 | Radioactive preparation capable of promoting blood circulation and dredging meridians for cataract patients and preparation thereof |
CN105641038A (en) * | 2016-03-26 | 2016-06-08 | 齐齐哈尔市前进医药有限责任公司 | Yanmaitong eyedrops and preparation method thereof |
CN107496806A (en) * | 2017-09-07 | 2017-12-22 | 成都兴倍加生物科技有限责任公司 | A kind of pill medicine for treating cataract of old people and preparation method thereof |
CN108175819A (en) * | 2018-03-07 | 2018-06-19 | 黑龙江中医药大学 | It is a kind of to be used to treat Chinese medicine composition of cataract and its preparation method and application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101972340A (en) * | 2010-10-08 | 2011-02-16 | 张继成 | Traditional Chinese medicine composition for tonifying liver and improving eyesight |
CN102784301A (en) * | 2012-07-18 | 2012-11-21 | 黄平县润发药业农民专业合作社 | Traditional Chinese medicine treating early cataract and its preparation method |
CN102949540A (en) * | 2012-11-20 | 2013-03-06 | 孙斌 | Traditional Chinese medicinal composite for treating cataract |
-
2013
- 2013-10-25 CN CN201310509764.9A patent/CN103520621B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101972340A (en) * | 2010-10-08 | 2011-02-16 | 张继成 | Traditional Chinese medicine composition for tonifying liver and improving eyesight |
CN102784301A (en) * | 2012-07-18 | 2012-11-21 | 黄平县润发药业农民专业合作社 | Traditional Chinese medicine treating early cataract and its preparation method |
CN102949540A (en) * | 2012-11-20 | 2013-03-06 | 孙斌 | Traditional Chinese medicinal composite for treating cataract |
Non-Patent Citations (3)
Title |
---|
刘佑云: "中医中药治疗老年性白内障", 《中国药业》 * |
孙熠等: "年龄相关性白内障的中医药治疗", 《国际眼科杂志》 * |
谭秋元: "活血祛障汤治疗老年性白内障200例疗效观察", 《湖南中医杂志》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103860942A (en) * | 2014-03-31 | 2014-06-18 | 刘洁 | Drug for treating phlegm turbidity nasopharynx cancer and preparation method thereof |
CN104288645A (en) * | 2014-10-27 | 2015-01-21 | 邓维新 | Traditional Chinese medicine for treating senile cataract |
CN104707006A (en) * | 2015-03-03 | 2015-06-17 | 李军 | Radioactive preparation capable of promoting blood circulation and dredging meridians for cataract patients and preparation thereof |
CN104623318A (en) * | 2015-03-12 | 2015-05-20 | 周晓明 | Traditional Chinese medicine preparation for pterygium and preparation method of traditional Chinese medicine preparation |
CN105641038A (en) * | 2016-03-26 | 2016-06-08 | 齐齐哈尔市前进医药有限责任公司 | Yanmaitong eyedrops and preparation method thereof |
CN107496806A (en) * | 2017-09-07 | 2017-12-22 | 成都兴倍加生物科技有限责任公司 | A kind of pill medicine for treating cataract of old people and preparation method thereof |
CN108175819A (en) * | 2018-03-07 | 2018-06-19 | 黑龙江中医药大学 | It is a kind of to be used to treat Chinese medicine composition of cataract and its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
CN103520621B (en) | 2015-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104435775A (en) | Chinese medicinal health-care spirit and preparation method thereof | |
CN103520621B (en) | A kind of Chinese medicine composition for the treatment of senile cataract and preparation method thereof | |
CN102068707A (en) | Traditional Chinese medicine contrast medium adjuvant used for B ultrasonic and preparation method thereof | |
CN103432475B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
CN103405728B (en) | A kind of Chinese medicine composition for the treatment of climacteric syndrome and preparation method thereof | |
CN103041264B (en) | Kudzuvine root brain-boosting and intelligence-boosting oral solution with function of preventing vascular dementia and preparation method thereof | |
CN102755596B (en) | Traditional Chinese medicine for treating phlegm-dampness hyperplasia of mammary glands and preparation method thereof | |
CN103638250B (en) | One treats prosopoplegic Chinese medicine preparation and preparation method thereof | |
CN103520655B (en) | Traditional Chinese medicine composition for treating psoriasis vulgaris and preparation method thereof | |
CN103316245B (en) | Chinese medicine preparation for treating infantile enuresis and preparation method thereof | |
CN104958646A (en) | Chinese medicinal preparation for relaxing bowels and preparation method thereof | |
CN105497816A (en) | Traditional Chinese medicine preparation for treating atherosclerosis and preparation method thereof | |
CN104547622A (en) | Traditional Chinese medicine preparation for treating cataract and preparation method of traditional Chinese medicine preparation | |
CN104274754A (en) | Traditional Chinese medicine composition for treating infantile enuresis and preparation method of traditional Chinese medicine composition | |
CN103041262A (en) | Traditional Chinese medicine enema for curing chronic prostatitis and preparing method thereof | |
CN103520643B (en) | A kind of Chinese medicine preparation being used for the treatment of diabetic cataract and preparation method thereof | |
CN103202964B (en) | Brain-improving and mind-calming medicinal liquor | |
CN104547494A (en) | Traditional Chinese medicine composition medicinal liquor for treating hyperthyroidism and preparation process | |
CN104689283A (en) | Medicine for treatment of spleen insufficiency damp-aggregating type chloasma and preparation method thereof | |
CN104623318A (en) | Traditional Chinese medicine preparation for pterygium and preparation method of traditional Chinese medicine preparation | |
CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
CN105560818A (en) | Medicine for treating cataract and preparation method thereof | |
CN104474440A (en) | Pharmaceutical composition for treatment of nutritional anemia of piglets and preparation method thereof | |
CN114246924A (en) | Pine and cypress health-care paste | |
CN102133289B (en) | Liver-protecting and face-beautifying granule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CENG QINGYUN Free format text: FORMER OWNER: LI DIANCHANG Effective date: 20150826 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zeng Qingyun Inventor before: Li Dianchang Inventor before: Liang Diecong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI DIANCHANG LIANG YICONG TO: CENG QINGYUN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150826 Address after: 46 Shandong provincial Chest Hospital, Lixia mountain road, Lixia District, Ji'nan, Shandong 250013, China Applicant after: Zeng Qingyun Address before: Shinan District 266073 Shandong city of Qingdao province No. 7 Yinchuan West Road, Yinhai No. 1 7-2-505 Applicant before: Li Dianchang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151014 Termination date: 20161025 |